Abstract:Generation of hiPSCs with multi‐gene modifications, including motor neuron‐specific transcription factors Ngn2, Isl1, and Lhx3 controlled by Tet‐On system and one anti‐apoptosis gene Bcl‐xL. The genetically modified hiPSCs survived and directionally differentiated into motor neurons after transplantation in vivo. The genetically modified hiPSCs partially converted into neural progenitors, serving as a spare cell resource. Objectives Transplantation of neural progenitor cells (NPCs) derived from human‐induced pluripotent stem cells (hiPSCs) is one of the promising treatment strategies for motor neuron diseases (MNDs). However, the inefficiency in committed differentiation of NPCs in vivo limits its application. Here, we tried to establish a potential therapeutic strategy for MNDs by in vivo directional differentiation of hiPSCs engineered with motor neuron (MN) specific transcription factors and Tet‐On system. Materials and Methods We engineered hiPSCs with three MN‐specific transcription factors and Tet‐On system. The engineered cells were directly transplanted into immunodeficient mice through subcutaneous, intra‐spinal cord and intracerebroventricular injections. Following doxycycline (Dox) induction, teratoma formation, and motor MN differentiation were evaluated. Results We generated genetically engineered hiPSCs, in which the expression of Ngn2, Isl1, and Lhx3 was controlled by a drug‐inducible transgenic system. These cells showed normal pluripotency and proliferative capacity, and were able to directionally differentiate into mature motor neurons (MNs) and NPCs with high efficiency in spinal cords and cerebral lateral ventricles under the induction of Dox. The grafts showed long‐term survival in the recipient mice without formation of teratoma. Conclusions The induced mature MNs and NPCs were expected to replace the damaged endogenous MNs directly, and play a role of de novo stem cell stock for long‐term neuron damage repair, respectively. Therefore, in vivo directional differentiation of the hiPSCs engineered with MN‐specific transcription factors and Tet‐On system via Dox induction could be a potential therapeutic strategy for MNDs with high efficacy and safety.

Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors: In Vitro and In Vivo Post-grafting Safety Characterization

Human neural progenitors derived from integration-free iPSCs for SCI therapy

Direct Induction of Neural Progenitor Cells Transiently Passes Through a Partially Reprogrammed State

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia

Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

A comprehensive protocol for efficient differentiation of human NPCs into electrically competent neurons

Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro

The Long-Term Survival and Functional Maturation of Human Inpc-Derived Neurons in the Basal Forebrain of Cynomolgus Monkeys

Efficient generation human induced pluripotent stem cells from human somatic cells with Sendai-virus

Exploring the Functional Heterogeneity of Directly Reprogrammed Neural Stem Cell-Derived Neurons via Single-Cell RNA Sequencing

Non-viral co-delivery of the four yamanaka factors for generation of human induced pluripotent stem cells via calcium phosphate nanocomposite particles

Characterization of Human-Induced Neural Stem Cells and Derivatives following Transplantation into the Central Nervous System of a Nonhuman Primate and Rats

Inducible motor neuron differentiation of human induced pluripotent stem cells in vivo

Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Showed Neuronal Differentiation, Neurite Extension, and Formation of Synaptic Structures in Rodent Ischemic Stroke Brains

Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation

Efficient induction of neural progenitor cells from human ESC/iPSCs on Type I Collagen

Generation of iPSCs Using Sendai Virus Vectors

Differentiation of human induced pluripotent stem cells into cortical neural stem cells